Alembic Pharmaceuticals Receives USFDA Approval for Diltiazem Hydrochloride Capsules
21 October, 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application…